Almujtama Alraida Medical Co.

SR 20.00As of Sun 8 Nov 2026, 12:00 UTC

Tadawul:9592Healthcare

Country Saudi Arabia

PE (Fwd) 22.84

TSR 3Y CAGR (12.89%)

Div yield —

ROE 6.35%

Pharmaceutical Retailers

Beta (5Y) —

PE TTM 22.64

TSR TTM (34.33%)

Mkt cap SR 190.0M

ROIC 5.04%

SE Grade™

—

Value

Quality

Moat

1Y Price

Reference

SR 21

6.26%

(14.61%)

Price above Reference Value

TTM

FYE 31 Dec SAR

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026E

Trend

10Y

Peers

454.7

RevenueSR M

—

367.1

407.7

430.8

454.7

484.2

7.40%

—

5.57

Revenue growth%

—

11.08

5.64

5.57

6.48

5.64

—

32.93

Gross margin%

—

32.34

31.69

32.99

32.93

32.89

32.64

—

2.36

Operating margin%

—

7.40

3.42

1.80

2.36

2.11

2.89

—

1.85

Net margin%

—

5.20

2.79

1.84

1.85

1.70

2.32

—

22.64

P/E ratio (avg)x

—

25.02

37.41

35.35

23.15

35.35

—

17.08

EV/EBITx

—

31.61

60.08

—

17.93

45.84

—

13.15

FCF yield (avg)%

—

23.91

14.72

8.43

15.86

14.72

—

5.50

FCF margin%

—

5.05

16.71

10.14

5.50

6.22

7.82

—

2.978

FCF / Net incomex

—

0.972

5.981

5.508

2.978

3.672

4.243

—

5.04

ROIC%

—

11.44

6.55

3.13

5.04

8.04

5.79

—

6.35

Return on equity%

—

16.09

15.09

9.30

6.35

6.29

12.19

—

1.63

Return on assets%

—

5.70

2.58

1.73

1.63

1.50

2.15

—

0.88

EPSSR

—

2.01

1.20

0.83

0.88

0.86

(23.95%)

—

5.86

EPS growth%

—

(40.28)

(30.42)

5.86

(2.18)

(30.42)

—

13.30

Bookvalue per shSR

—

12.48

3.41

14.54

13.30

14.16

2.13%

—

2.63

FCF per shareSR

—

1.95

7.17

4.60

2.63

3.17

10.47%

—

Dividend per shSR

—

Div yield (avg)%

—

Payout ratio%

—

9.500

Shares (diluted)M

—

9.500

—

◌9.500

—

Buyback yield%

—

D/E ratiox

—

1.038

5.209

1.234

—

1.234

—

183.1

Enterprise valueSR M

—

440.9

464.8

—

183.1

5.42%

—

LT debtSR M

—

Peers (US$51.46M)

Cap (US$)

Middle East Pharmaceut…

623.6M

20.90x

Qomel Company Limited

65.44M

35.24x

Al-Razi Medical Company

9.404M

30.47x

CG Invites Co., Ltd.

45.64M

144.1x

Capital

TTM

10Y

Leveragex

—

7.981

EBIT/Intx

1.159

1.733

Own earn%

—

Sh yield%

—

Owners

Insiders/Inst%

55.87

5.49

Short interest%

—

SBC / revenue%

—

Record

10Y

Profitable years

4/4

Revenue growth years

3/3

EPS growth years

1/3

Dividend streakyrs

Op margin range%

2–7

$1 testx

—

Incr. ROIC%

—

Almujtama Alraida Medical Co. operates pharmacies in Saudi Arabia. The company provides pharmaceutical services; and a magazine related to medical and pharmaceutical health field. It also offers its products through online. The company was founded in 2001 and is based in Jeddah, Saudi Arabia.

Growth vs revenue

Latest

Trend

3Y CAGR

Rel growth

Revenue

SR 454.7M

7.40%

1.00×

Cost of revenue

SR 305.0M

7.08%

0.99×

Operating expenses

SR 139.0M

14.95%

1.23×

Asset mix

Trend

Other

98.66%

Cash and investments

1.34%

Reinvestment returns

5Y median

Trend

Reinvestment rate

n/m

Return on capital

5.79%

Spread over hurdle

(0.47%)